Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX STOCKHOLM  >  Probi AB (publ)    PROB   SE0001280355

PROBI AB (PUBL)

(PROB)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

Probi publ : Annual General Meeting 2020

share with twitter share with LinkedIn share with facebook
05/13/2020 | 10:21am EDT

On Probi's Annual General Meeting on 13 May 2020 in Lund, the following was resolved:

· The Annual General Meeting approved the Annual Report and the Board's proposal on a dividend for the financial year 2019 corresponding to SEK 1.00 per share. The record date was set to 15 May 2020.

· The Annual General Meeting discharged the Board members and the CEO from liability for the financial year 2019.

· The Annual General Meeting resolved that the Board shall consist of five members without any deputies. The meeting re-elected the members Jörn Andreas, Irène Corthésy Malnoë, Charlotte Hansson and Jean-Yves Parisot and resolved on new election of Malin Ruijsenaars. Jean-Yves Parisot was re-elected as Chairman of the Board.

· The Board fee was determined to a total of SEK 1,750,000, whereof SEK 500,000 to the Chairman and SEK 250,000 to each of the other members. In addition, fee for committee work was determined to SEK 100,000 to the Chairman of the Audit Committee and SEK 50,000 to the other members, and SEK 30,000 to Chairman of the Remuneration Committee and SEK 20,000 to the other members.

· The Annual General Meeting re-elected the registered public accounting firm Ernst & Young AB, which had informed that Peter Gunnarsson should be the auditor in charge.

· The Board's proposal regarding guidelines for remuneration of senior executives was approved.

· The Board was authorized, in accordance with its proposal, for the period until the next AGM and on one or several occasions, to resolve on repurchase and transfers of own shares.

· The Board was authorized, in accordance with its proposal, for the period until the next AGM and on one or several occasions, to resolve on the issue of a maximum of 1,164,412 shares.

· The Annual General Meeting appointed a nomination committee ahead of the Annual General Meeting 2021 consisting of Heinz-Jürgen Bertram (Symrise), Jannis Kitsakis (Fourth Swedish National Pension Fund), Marianne Flink (Swedbank Robur funds) and Bengt Jeppsson (Professor, Surgical Faculty, Lund University, representing the minor shareholders).

Presentation from the CEO will be available on www.probi.com.

FOR FURTHER INFORMATION, CONTACT:
Tom Rönnlund, CEO: tel + 46 46 286 89 40, e-mail: trd@probi.com
Henrik Lundkvist, CFO: tel + 46 46 286 89 41, e-mail: henrik.lundkvist@probi.com

ABOUT PROBI
Probi AB is a Swedish publicly traded bioengineering company. Probi's vision is to help people live healthier lives by delivering effective and well-documented probiotics, with proven health benefits based on scientific research. Founded by scientists in Sweden in 1991, Probi is a multinational company, active in more than 40 markets around the world and holding over 400 patents worldwide. In 2019, Probi had net sales of MSEK 626. The Probi share is listed on Nasdaq Stockholm, Mid Cap. Probi had about 4,000 shareholders on December 31, 2019. Read more at www.probi.com.

https://news.cision.com/probi/r/probi-s-annual-general-meeting-2020,c3110917

https://mb.cision.com/Main/1556/3110917/1247188.pdf

(c) 2020 Cision. All rights reserved., source Press Releases - English

Stocks mentioned in the article
ChangeLast1st jan.
PROBI AB (PUBL) -2.95% 313 Delayed Quote.40.99%
SYMRISE AG -0.71% 104.5 Delayed Quote.11.41%
share with twitter share with LinkedIn share with facebook
Latest news on PROBI AB (PUBL)
07/02PROBI PUBL : and Örebro University to collaborate on research into exploration o..
AQ
05/14PROBI PUBL : A true pioneer in probiotic research is elected NutraChampion 2020
AQ
05/14PROBI AB (PUBL) : Ex-dividend day for final dividend
FA
05/13PROBI PUBL : ´s Annual General Meeting 2020
PU
05/13PROBI PUBL : Annual General Meeting 2020
AQ
04/24Q1 2020 : A solid start to the year
AQ
04/21PROBI PUBL : Presentation of Probi's Q1 report 2020
PU
04/21PROBI PUBL : Presentation of Probi's Q1 report 2020
AQ
04/08PROBI PUBL : publishes Annual and Sustainability Report for 2019
AQ
04/07PROBI PUBL : Notice to Annual General Meeting in Probi AB (publ)
AQ
More news
Financials
Sales 2020 665 M 71,9 M 71,9 M
Net income 2020 71,0 M 7,68 M 7,68 M
Net cash 2020 222 M 24,0 M 24,0 M
P/E ratio 2020 50,0x
Yield 2020 0,26%
Capitalization 3 566 M 386 M 386 M
EV / Sales 2019
EV / Sales 2020 5,03x
Nbr of Employees -
Free-Float 39,2%
Chart PROBI AB (PUBL)
Duration : Period :
Probi AB (publ) Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PROBI AB (PUBL)
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
 
Mean consensus -
Number of Analysts 2
Average target price
Last Close Price 313,00 
Spread / Highest target -
Spread / Average Target -
Spread / Lowest Target -
EPS Revisions
Managers
NameTitle
Tom Juhani Rönnlund Chief Executive Officer
Jean-Yves Parisot Chairman
Andy McShea Vice President-Operations
Henrik Lundkvist Chief Financial Officer
Niklas Brandt Vice President-Information Technology
Sector and Competitors
1st jan.Capitalization (M$)
PROBI AB (PUBL)40.99%386
BY-HEALTH CO., LTD.29.34%4 648
BALCHEM CORPORATION-8.09%3 010
THE SIMPLY GOOD FOODS COMPANY-25.75%2 008
MEDIFAST, INC.36.72%1 765
KOLMARBNH CO LTD--.--%1 254